- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Myung In Pharm Co Ltd (317450)
Myung In Pharm Co Ltd stock price live, this page displays KS 317450 stock exchange data. View the 317450 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Myung In Pharm Co Ltd real time stock price chart below.
What Is the Myung In Pharm Co Ltd Stock Price Today?
The Myung In Pharm Co Ltd stock price today is 57,900.
What Is the Stock Symbol for Myung In Pharm Co Ltd?
The stock ticker symbol for Myung In Pharm Co Ltd is 317450.
Is 317450 the Same as $317450?
$317450 is a common way to refer to the Myung In Pharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Myung In Pharm Co Ltd Trade On?
Myung In Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Myung In Pharm Co Ltd a Good Stock to Buy?
Determining whether Myung In Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Myung In Pharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 317450 quote. (ISIN: KR7317450005)
What Is the Myung In Pharm Co Ltd Stock Price Today?
The Myung In Pharm Co Ltd stock price today is 57,900.
What Is the Stock Symbol for Myung In Pharm Co Ltd?
The stock ticker symbol for Myung In Pharm Co Ltd is 317450.
Is 317450 the Same as $317450?
$317450 is a common way to refer to the Myung In Pharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Myung In Pharm Co Ltd Trade On?
Myung In Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Myung In Pharm Co Ltd a Good Stock to Buy?
Determining whether Myung In Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Myung In Pharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 317450 quote. (ISIN: KR7317450005)
Seoul
Currency in KRW
57,900
+1,600(+2.84%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57,000
57,900
52 wk Range
52,000
134,500
317450 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57,00057,900
52 wk Range
52,000134,500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
317450 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Myung In Pharmaceutical LTD., a pharmaceutical company, manufactures ETC and OTC drugs. It offers products in the areas of thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, adhd, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation agent, nutrition supplements and other pharmaceuticals. The company also provides APIs, such as benztropine mesylate, benidipine hcl, clopidogrel bisulfate, haloperidol, paroxetine hcl, pimozide, quetiapine fumarate, rasagiline mesylate, risperidone, sumatriptan succinate, trazodone hci, triazolam, levetiracetam, carbamazepine, benserazide hydrochloride, escitalopram oxalate, vortioxetine hbr, brivaracetam, edoxban tosylate, opicapone, brexpiprazole, guanfacine hydrochloride, lacosamide, lurasidone hydrochloride. Myung In Pharmaceutical LTD. was founded in 1985 and is based in Hwaseong-si, South Korea.
Compare 317450 to Peers and Sector
Metrics to compare | 317450 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship317450PeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.2x | 9.6x | −0.5x | |
PEG Ratio | 1.08 | −0.12 | 0.00 | |
Price / Book | 1.0x | 0.7x | 2.6x | |
Price / LTM Sales | 2.9x | 0.8x | 3.2x | |
Upside (Analyst Target) | - | 36.4% | 47.6% | |
Fair Value Upside | Unlock | 33.9% | 6.1% | Unlock |
Earnings
Latest Release
Mar 18, 2026
EPS / Forecast
1,590.00 / --
Revenue / Forecast
72.09B / --
People Also Watch
FAQ
What Is the Myung In Pharm (317450) Stock Price Today?
The Myung In Pharm stock price today is 57,900 KRW.
What Stock Exchange Does Myung In Pharm Trade On?
Myung In Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for Myung In Pharm?
The stock symbol for Myung In Pharm is "317450."
Does Myung In Pharm Pay Dividends? What’s The Current Dividend Yield?
The Myung In Pharm dividend yield is 2.59%.
What Is the Myung In Pharm Market Cap?
As of today, Myung In Pharm market cap is 845.34B KRW.
What Is Myung In Pharm's Earnings Per Share (TTM)?
The Myung In Pharm EPS (TTM) is 6,718.
From a Technical Analysis Perspective, Is 317450 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Myung In Pharm Stock Split?
Myung In Pharm has split 0 times.
How Many Employees Does Myung In Pharm Have?
Myung In Pharm has 335 employees.
What is the current trading status of Myung In Pharm (317450)?
As of Apr 15, 2026, Myung In Pharm (317450) is trading at a price of 57,900 KRW, with a previous close of 57,900 KRW. The stock has fluctuated within a day range of 57,000 KRW to 57,900 KRW, while its 52-week range spans from 52,000 KRW to 134,500 KRW.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.